References
- Miner JR , MelsonTI , LeimanDet al. Pooled Phase III safety analysis of sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain. Pain Manag.9(3), 259–271 (2019).
- Hersch C , DenisC , DalmaS. Frequency, nature and management of patient-reported severe acute pain episodes in the over-the-counter setting: results of an online survey. Pain Manag.9(4), 379–387 (2019).
- Taylor HS , DunEC , ChwaliszK. Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain. Pain Manag.9(5), 497–515 (2019).
- Khan SP , PickensTA , BerlauDJ. Perspectives on cannabis as a substitute for opioid analgesics. Pain Manag.9(2), 191–203 (2019).
- Philpot U , JohnsonMI. Diet therapy in the management of chronic pain: better diet less pain?Pain Manag.9(4), 335–338 (2019).
- Loeser JD . A new way of thinking about pain. Pain Manag.9(1), 5–7 (2019).
- Kumar P . Hemiplegic shoulder pain in people with stroke: present and the future. Pain Manag.9(2), 107–110 (2019).
- Bough A . Welcome to the ninth volume of Pain Management. 9(1), 1–4 (2019).
- Pain Management journal. Twitter (2019). https://twitter.com/fsgpmt
- Neuro Central (2019). http://www.neuro-central.com/
- Future Science Group Neuro Central . LinkedIn (2019). http://www.linkedin.com/company/neuro-central/